← Leaderboards
Roger Keith Reeves
University Of Maryland Baltimore
$28,096,305
Attributed
$37,705,657
Total exposure
20
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9M · FY2013–25$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$42,580,045 · 21
By mechanism
R01$30,514,228 · 9
U54$4,874,388 · 1
P30$2,816,013 · 3
R21$2,575,961 · 6
U01$1,082,429 · 1
R56$717,026 · 1
Top collaborators
- Stephanie Jost11 shared
- Qingsheng Li5 shared
- Yuxing Li5 shared
- Amitinder Kaur4 shared
- Sallie R. Permar4 shared
- Cliburn C Chan2 shared
- Cordelia Manickam2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Yuxing Li$12,368,734
- Cristiana Cairo$3,720,576
- Sarah Boudova$110,850
- Meagan Elise Deming$502,779
- Miriam K Laufer$32,646,632
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMediatingInfectionNatural Killer CellsResponseTissuesVirusImmuneMacacaPlayNonhuman PrimateVirus DiseasesViralPhenotypePrimatesAntibodiesIn VivoMemoryExhibitsMacaca MulattaChronicAntigensVaccinesCell Physiology
Grant awards (68)
Center for Multiscale Immune Systems Modeling$4,874,388
U54 · FY2025 · AI
Multiscale Modeling of Influenza Neutralizing Antibody and Fc Effector Biology$1,082,429
U01 · FY2025 · AI
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV$803,093
R01 · FY2025 · AI · contact PI
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells$744,953
R01 · FY2025 · AI
Role of maternal-fetal interface NK cells in pregnancy maintenance and congenital CMV transmission$698,695
R01 · FY2025 · HD
Developmental Core$588,306
P30 · FY2025 · AI · contact PI
Harnessing CD89+ NK Cells for Novel Therapeutic Interventions Against HIV/SIV$201,250
R21 · FY2025 · AI · contact PI
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV$806,931
R01 · FY2024 · AI · contact PI
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells$760,892
R01 · FY2024 · AI
Role of maternal-fetal interface NK cells in pregnancy maintenance and congenital CMV transmission$699,071
R01 · FY2024 · HD
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV$570,974
R01 · FY2024 · AI · contact PI
Harnessing CD89+ NK Cells for Novel Therapeutic Interventions Against HIV/SIV$217,350
R21 · FY2024 · AI · contact PI
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV$810,895
R01 · FY2023 · AI · contact PI
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir$778,402
R01 · FY2023 · AI
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells$773,933
R01 · FY2023 · AI
Role of maternal-fetal interface NK cells in pregnancy maintenance and congenital CMV transmission$711,943
R01 · FY2023 · HD
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles$408,166
R01 · FY2023 · AI · contact PI
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease$402,500
R01 · FY2023 · DK · contact PI
Advanced Lab Technologies Core$317,952
P30 · FY2023 · AI · contact PI
Role of eosinophils in SIV infection$201,250
R21 · FY2023 · AI
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV$1,049,013
R01 · FY2022 · AI · contact PI
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells$784,398
R01 · FY2022 · AI
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir$778,402
R01 · FY2022 · AI
Role of maternal-fetal interface NK cells in pregnancy maintenance and congenital CMV transmission$754,314
R01 · FY2022 · HD
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles$674,488
R01 · FY2022 · AI · contact PI
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease$402,500
R01 · FY2022 · DK · contact PI
Advanced Lab Technologies Core$341,018
P30 · FY2022 · AI · contact PI
Role of eosinophils in SIV infection$241,500
R21 · FY2022 · AI
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV$881,222
R01 · FY2021 · AI · contact PI
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir$778,402
R01 · FY2021 · AI
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles$697,598
R01 · FY2021 · AI · contact PI
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells$662,843
R01 · FY2021 · AI
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease$402,500
R01 · FY2021 · DK · contact PI
Advanced Lab Technologies Core$356,151
P30 · FY2021 · AI · contact PI
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection$177,986
R21 · FY2021 · AI · contact PI
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection$73,471
R21 · FY2021 · AI · contact PI
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines$839,952
R01 · FY2020 · AI · contact PI
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir$778,402
R01 · FY2020 · AI
Mechanisms of innate modulation of SIV reservoirs and opportunistic disease in the oral cavity$663,276
R01 · FY2020 · DE · contact PI
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles$620,422
R01 · FY2020 · AI · contact PI
Advanced Lab Technologies Core$455,294
P30 · FY2020 · AI · contact PI
Microbial and innate immune mechanisms of oral inflammation during SIV infection$433,664
R01 · FY2020 · DE · contact PI
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection$210,000
R21 · FY2020 · AI · contact PI
Microbial and innate immune mechanisms of oral inflammation during SIV infection$209,300
R01 · FY2020 · DE · contact PI
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines$36,640
R01 · FY2020 · AI · contact PI
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines$876,592
R01 · FY2019 · AI · contact PI
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir$805,652
R01 · FY2019 · AI
Microbial and innate immune mechanisms of oral inflammation during SIV infection$704,579
R01 · FY2019 · DE · contact PI
Mechanisms of innate modulation of SIV reservoirs and opportunistic disease in the oral cavity$663,276
R01 · FY2019 · DE · contact PI
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles$659,902
R01 · FY2019 · AI · contact PI
Advanced Lab Technologies Core$424,786
P30 · FY2019 · AI · contact PI
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines$876,592
R01 · FY2018 · AI · contact PI
Microbial and innate immune mechanisms of oral inflammation during SIV infection$704,579
R01 · FY2018 · DE · contact PI
Mechanisms of innate modulation of SIV reservoirs and opportunistic disease in the oral cavity$663,276
R01 · FY2018 · DE · contact PI
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines$876,592
R01 · FY2017 · AI · contact PI
Mechanisms of innate modulation of SIV reservoirs and opportunistic disease in the oral cavity$723,779
R01 · FY2017 · DE · contact PI
Microbial and innate immune mechanisms of oral inflammation during SIV infection$675,389
R01 · FY2017 · DE · contact PI
Microbial and innate immune mechanisms of oral inflammation during SIV infection$510,388
R01 · FY2017 · DE · contact PI
Mechanisms of innate modulation of SIV reservoirs and opportunistic disease in the oral cavity$723,779
R01 · FY2016 · DE · contact PI
Microbial and innate immune mechanisms of oral inflammation during SIV infection$632,069
R01 · FY2016 · DE · contact PI
Advanced Technologies Core$332,506
P30 · FY2016 · AI · contact PI
Innate Lymphoid Cell Modulation of SIV Transmission and Pathogenesis$201,220
R21 · FY2016 · AI · contact PI
Enhancing Resolution of Memory NK cells in CMV- and SIV-infected macaques$165,907
R21 · FY2016 · AI · contact PI
Antigen-Specific NK Cell Memory Against SIV and SIV Vaccines$717,026
R56 · FY2015 · AI · contact PI
Innate Lymphoid Cell Modulation of SIV Transmission and Pathogenesis$214,380
R21 · FY2015 · AI · contact PI
Enhancing Resolution of Memory NK cells in CMV- and SIV-infected macaques$191,647
R21 · FY2015 · AI · contact PI
Role of NK Cells in GBV-B Infection: Modeling HCV Clearance and Control$217,500
R21 · FY2014 · AI · contact PI
Role of NK Cells in GBV-B Infection: Modeling HCV Clearance and Control$262,500
R21 · FY2013 · AI · contact PI